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Multimodal brain monitoring has been utilized to optimize treatment of patients with critical neurological diseases. However, the
amount of data requires an integrative tool set to unmask pathological events in a timely fashion. Recently we have introduced
a mathematical model allowing the simulation of pathophysiological conditions such as reduced intracranial compliance and
impaired autoregulation. Utilizing a mathematical tool set called selected correlation analysis (sca), correlation patterns, which
indicate impaired autoregulation, can be detected in patient data sets (scp). In this study we compared the results of the sca with
the pressure reactivity index (PRx), an established marker for impaired autoregulation. Mean PRx values were significantly higher
in time segments identified as scp compared to segments showing no selected correlations (nsc).The sca based approach predicted
cerebral autoregulation failure with a sensitivity of 78.8% and a specificity of 62.6%. Autoregulation failure, as detected by the
results of both analysis methods, was significantly correlated with poor outcome. Sca of brain monitoring data detects impaired
autoregulation with high sensitivity and sufficient specificity. Since the sca approach allows the simultaneous detection of both
major pathological conditions, disturbed autoregulation and reduced compliance, it may become a useful analysis tool for brain
multimodal monitoring data.
1. Introduction
Neurocritical care management of patients with life-threat-
ening diseases of the nervous system aims to avoid secondary
brain injury [1]. This requires early detection of physical and
biochemical events leading to increased intracranial pressure
(ICP), insufficient cerebral blood flow, and brain hypoxia
[2]. Since clinical signs of deterioration are confounded by
therapeutic interventions such as sedation and analgesia, suc-
cessful treatment interventions depend on continuous, real-
time measurements of a variety of physiologic parameters
[3]. However, the clinician may be confronted with more
than 200 variables when evaluating a patient leading to an
information overflow with a risk of misguided management
decisions [4]. Consequently, in a recent consensus statement
of the Neurocritical Care Society, the need for innovative
data interpretation systems for early visualization of changes
in the cerebral autoregulation and intracranial compliance
status was defined to optimize treatment of each individual
patient [5]. To generate a tool set which might facilitate
detection of critical worsening of the patient, a mathematical,
compartmental model of the brain focusing on slow dynamic
variations was developed. This model allows simulating
changes of brain multimodal monitoring data triggered by
pathophysiological events such as reduced intracranial com-
pliance and impaired autoregulation [6, 7]. In a second step,
we attempted to detect the pattern of brain monitoring
parameter changes predicted by the model upon simulation
of impaired autoregulation in patients’ data sets utilizing
selected correlation analysis [8, 9]. Upon recognition of a
specific data pattern, this approach directly allows drawing
conclusions about the status of the patient with specific focus
on intracranial compliance and cerebral autoregulation. In
earlier studies, a key element of cerebral autoregulation, the
pressure reactivity index (PRx), was established [10]. This
index reflects the changes of cerebrovascular smooth muscle
tone in response to slow spontaneous changes of arterial
blood pressure (ABP). Under physiological conditions, a rise
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in ABP will induce cerebrovascular constriction leading to
reduced cerebral blood volume and decreased ICP. Tech-
nically, the index is calculated as a short-term “moving”
Pearson correlation between 10-second averages of ABP and
ICP waveforms over a period of 300 seconds [10]. A positive
index indicates loss of vascular pressure reactivity which
can be interpreted as impaired autoregulation.This approach
has been extensively validated utilizing transcranial Doppler
sonography and laser Doppler flowmetry [11, 12], microdialy-
sis [13], PET-based CBF measurements [14], and experimen-
tal animal models [15]. In addition, this index has not only
been established as a strong prognostic marker [16, 17] but
also demonstrated to be useful for the determination of a
patient specific optimal cerebral perfusion pressure (CPPopt)
[18]. The goal of the current study is to compare time seg-
ments of impaired autoregulation as determined by selected
correlation analyses with the results of PRx calculations at
the identical observational window. We hypothesized that if
our assessment regarding impaired cerebral autoregulation
based on the pattern recognition approach is correct, the
PRx results should confirm this with pathologically increased
index results.
2. Methods
2.1. Patient Population. The study was conducted in accor-
dance with the ethical guidelines of the University Regens-
burg Institutional Review Board. Informed consent was
obtained from the patient’s relatives; all study results were
stored and analyzed anonymously. We collected data from
29 patients (13 female, 16 male) who were treated for sub-
arachnoid hemorrhage (𝑛 = 19) or traumatic brain injury
(𝑛 = 10) at our neurosurgical ICU and who underwent brain
multimodal monitoring. A detailed description of patient
characteristics is provided in Table 1. The mean age was
44.8 years (range: 72.4–16.4); the median Glasgow Coma
Scale GCS at the time of admission was 7 (range: 3–14). All
patients were sedated andmechanically ventilated during the
observation period. ICP monitoring was performed using
either an external ventricular drain (EVD) or a parenchymal
ICP probe (Raumedic, Helmbrechts, Germany); 10 patients
(34.5%) received decompressive craniectomy due to severe
brain swelling. Follow-up was completed up to October 2015
by reviewing outpatient records and contacting the patients,
a family member, or the patient’s primary physician. The
mean follow-up time was 48.3 months; no patient was lost
for follow-up. The neurological outcome was measured by
the Glasgow Outcome Scale (GOS) at the last follow-up; the
median score at the last follow-up was 3 (range: 1–5, Table 1).
2.1.1. Selected Correlation Analysis. Selected correlation anal-
ysis (SCA) [8] represents the combination of a windowing
technique with multiple frequency domain analysis (FDA) to
detect correlations between two time series in a time-resolved
way. In simple terms, frequency domain analysis decomposes
a time series into a bunch of sinusoidal waves with fixed
amplitude and frequency. Subsequently, information about
relevant components of the signal or correlated components
of two signals is identified. For this kind of analysis we use the
so-called multitaper method (MTM), a sophisticated tech-
nique to calculate robust power spectra and coherences from
short and noisy time series. To realize a time resolution, the
time series are split into consecutive segments of fixed length.
A pair of such segments, or windows, is used to calculate
multitaper power spectra of each window and the multitaper
coherence spectrum between both windows. From this spec-
tral information, an index called selected correlation (sc) is
deduced that reflects the strength of correlation between the
data segments within a specific frequency band. Additionally,
a differentiation between a positive correlation (scp) and a
negative one (scn) is achieved by calculating themeanHilbert
phase difference of this segments.
As input data we have used synchronously recorded time
series of ABP and ICP data, resampled to a sampling rate
of 0.2Hz. A correlation was called positive (scp) if the sc
index was higher than a predefined limit of 0.0555556, and
the mean Hilbert phase difference (mhpd) was lower than
70∘. Conversely, if the sc index was below the mentioned
limit and the Hilbert phase difference was between 70∘ and
110∘, the segment was classified as uncorrelated (no selected
correlation = nsc).
2.1.2.Mathematical Framework. Adetailed description of the
mathematical methods is published in in a previous paper
[19]; a brief summary is provided as follows.
Let 𝑋 fl {𝑥1, . . . , 𝑥𝑁} be a time series of length 𝑁. A
window of this time series can be represented as a function
in time, defined by its starting point 𝑘 and its length s:
𝑋𝑠,𝑘 (𝑡)
fl {𝑥𝑘+𝑡−1 ∈ 𝑋 | 1 ≤ 𝑡 ≤ 𝑠; 𝑘 + 𝑠 − 1 ≤ 𝑁; 𝑠 ≡ 2𝑢∈N} .
(1)
Using such windows as input for frequency domain analysis
by computing a multitaper power spectrum (mtms) of one
window or the multitaper coherence spectrum (mtmc) of
a pair of windows will transform the discrete time domain
of the time series, indexed by t, into the discrete frequency
domain of the spectra, indexed by 𝑓 with range 1 ≤ 𝑓 ≤ 𝑠/2.
Hence we define two functions realizing this transform:
𝑆𝑠 (𝑘, 𝑓) fl mtms of𝑋𝑠,𝑘 (𝑡) ,
𝐶𝑠 (𝑘, 𝑙, 𝑓) fl mtmc of𝑋𝑠,𝑘 (𝑡) , 𝑌𝑠,𝑙 (𝑡) . (2)
MTM contains a significance test which includes a number
of different significance levels. Therefore, every specific fre-
quency 𝑓 can be tested for significance. Based on this, we
proceed to define a tuple called pointwise selected correlation
(PSC) assuming a fixed significance level 𝐶:
PSC𝑠 (𝑘, 𝑙) fl (psc1, . . . , psc𝑠/2)
with: psc𝑓 fl
{{{
1 if 𝑆𝑠 (𝑘, 𝑓) ∧ 𝑆𝑠 (𝑙, 𝑓) ∧ 𝐶𝑠 (𝑘, 𝑙, 𝑓) significant
0 otherwise.
(3)
The requirement to be significant in both spectra ensures that
only frequencies are considered, which essentially contribute
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Table 1: Characteristics of patients, receiving treatment for either SAH (subarachnoid hemorrhage) or TBI (traumatic brain injury) who
were included in the study.The initial levels of consciousness at admission according to the Glasgow Coma Scale is depicted in column GCS;
patients receiving decompressive craniectomy due to brain swelling are indicated by “y”; the next column describes the brain monitoring
time for each patient in hours; outcome at last follow-up is noted in column GOS. The mean ICP and PRx columns describe the mean ICP
and PRx values averaged over the entire observation time per patient.
Gender Age Diagnosis GCS Decompressivecraniectomy
Monitoring
time (hours)
GOS
(last follow-up)
Mean ICP
(mmHG)
Mean
PRx
M 44.1 SAH 3 n 25.9 5 7.6 0.177
M 60.2 TBI 10 n 73.6 3 13.2 0.263
M 72.4 TBI 14 y 115.9 3 8.4 0.253
M 21.9 TBI 3 y 126.9 5 11.5 −0.078
M 51.6 SAH 8 n 136.7 1 20.8 0.412
F 51.6 SAH 9 n 162.6 3 9.7 0.255
M 65.4 TBI 6 y 184.3 3 9.7 0.172
F 26.2 TBI 7 y 187.2 5 14.8 −0.030
M 53.0 SAH 3 n 193.3 1 19.6 0.388
M 43.4 SAH 3 y 212.7 4 9.3 0.229
F 50.4 SAH 14 n 217.7 5 11.0 0.159
F 38.4 SAH 12 n 248.3 3 9.0 0.047
F 49.0 SAH 6 n 256.3 4 11.2 0.281
M 35.4 TBI 7 n 262.3 4 11.4 0.265
F 43.4 SAH 11 n 262.6 1 15.6 0.341
F 58.4 SAH 3 n 280.9 3 12.8 −0.008
M 18.5 TBI 3 y 289.8 3 11.4 −0.177
F 32.3 SAH 3 n 294.8 5 15.7 0.151
M 16.4 TBI 3 n 321.9 2 9.9 0.161
F 65.8 SAH 14 y 336.4 1 25.1 0.177
F 42.4 SAH 14 n 351.9 3 9.5 0.118
M 36.5 TBI 8 y 379.2 5 12.9 0.138
F 26.5 SAH 3 n 383.5 3 16.4 0.242
M 59.3 SAH 6 n 386.6 4 10.0 0.232
M 36.3 SAH 12 n 404.2 3 12.5 0.133
M 33.6 TBI 3 n 404.5 4 11.4 −0.152
F 62.8 SAH 11 y 453.9 3 10.7 −0.003
M 51.0 SAH 7 n 484.5 3 15.3 0.235
F 52.1 SAH 3 y 600.2 4 8.6 0.034
to the original signals. In case of the coherence spectrum,
this requirement assures that a specific 𝑓 shows a correlation
between the input signals. From the above-mentioned PSC,
we can calculate 𝑛 successive pairs of isochronous windows
leading to the mean pointwise selected correlation (MPSC):
MPSC𝑠 (𝑓) fl ( 1𝑁) ∗
𝑗=𝑁∑
𝑗=1
PSC𝑠𝑓 (𝑗, 𝑗) . (4)
MPSC describes the fraction of a significant occurrence in
both spectra and the coherence calculation for each single
frequency 𝑓. Utilizing MPSC it is possible to identify fre-
quency intervals that contain the information about potential
correlations within a data set. Following the identification of
such a frequency interval 𝑈 = (𝑚, . . . , 𝑛), it is possible to
determine periods in the data set where strong correlation
with respect to 𝑈 occurs. Subsequently, we determine the
correlation strength of a distinct pair of windows with respect
to 𝑈 by calculating the sum of all elements of PSC belonging
to the frequency band 𝑈. This sum, divided by the length of𝑈, is called selected correlation (sc):
sc𝑠,𝑚,𝑛 (𝑘, 𝑙) fl 1𝑛 − 𝑚 + 1
𝑓=𝑛∑
𝑓=𝑚
PSC𝑠𝑓 (𝑘, 𝑙)
with: 1 ≤ 𝑚 < 𝑛 ≤ 𝑠2 .
(5)
If the above-mentioned sc exceeds a predefined limit lsc,
this pair of windows is classified as selected correlation.
To obtain time-resolved information about the selected
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correlation we determine the index sc𝑠,𝑚,𝑛(?̃?) for isochronous
windows while shifting the starting point ?̃? along the time
axis:
sc𝑠,𝑚,𝑛 (?̃?) fl 1𝑛 − 𝑚 + 1
𝑓=𝑛∑
𝑓=𝑚
PSC𝑠𝑓 (?̃?, ?̃?)
with: 1 ≤ ?̃? ≤ 𝑁 − 𝑠 + 1.
(6)
In addition, we established a statistical test which calculates
error rates of false positives to determine the significance of
the threshold lsc.
2.2. Statistical Test. The statistical test for significance of lsc
is based on the model prediction of isochronous correlations
between ABP and ICP. In accordance with this, two segments
should not be correlated if they are not isochronous. Having
found a meaningful lsc we can count how often separated
windows produce sc values higher than lsc. The number of
wrong hits is interpreted as the error rate of sc with respect
to lsc. Now we introduce the so-called mean windowed
autocorrelation (mwa) to identify a sufficient offset between
the input windows, so that autocorrelation effects vanish:
mwa𝑠,𝑅,𝑚,𝑛 (𝑜) fl ( 1𝑅)
𝑖=𝑅∑
𝑖=1
sc𝑠,𝑚,𝑛 (𝑘𝑖, 𝑘𝑖 + 𝑜)
with: 𝑘𝑖 random.
(7)
For sufficiently large offset 𝑜, the subsequent mwa values
should be small and stable as autocorrelation artifacts should
be excluded. Subsequently, we can calculate the error index
ei𝑠,𝑚,𝑛(𝑘, 𝑙, lsc), indicating whether the selected correlation
sc𝑠,𝑚,𝑛(𝑘, 𝑙) is higher than a predefined limit lsc and the error
rate asc:
ei𝑠,𝑚,𝑛 (𝑘, 𝑙, lsc) fl {{{
1 if sc𝑠,𝑚,𝑛 (𝑘, 𝑙) > lsc
0 otherwise,
asc𝑠,𝑅,𝑚,𝑛,𝑜 (lsc) fl ( 1𝑅)
𝑖=𝑅∑
𝑖=1
ei𝑠,𝑚,𝑛 (𝑘𝑖, 𝑙𝑖, lsc)
with: 𝑘𝑖 random : 𝑙𝑖 > 𝑘𝑖 + 𝑜.
(8)
Accordingly, a pair of isochronous data segments is called sig-
nificantly correlated if the sc value of this pair is higher than
the predefined limit lsc. The significance of this correlation is
specified by the error rate of the given limit lsc.
2.3. Hilbert Phase Differences. Having identified a pair of
windows exhibiting a sufficient high correlation index sc, we
have to determine the phasing between the twodatawindows.
This is done by calculating the mean Hilbert phase difference
(mhpd) of the corresponding data segments, leading to values
of mhpd between 0 and 180 deg. The mhpd value is based on
the so-called Hilbert transform, a mathematical approach to
represent a real valued function 𝑠(𝑡) in the complex plain,
𝑠analytic (𝑡) fl 𝑠 (𝑡) + 𝑖 ∗ 𝑠 (𝑡) = 𝐴 (𝑡) ∗ 𝑒𝑖∗𝜑(𝑡)
with: 𝑠 (𝑡) fl 𝜋−1𝑃.𝑉. ∫∞
−∞
𝑠 (𝜏)
𝑡 − 𝜏𝑑𝜏.
(9)
Applying this transformation to the windows 𝑋𝑠,𝑘(𝑡), 𝑌𝑠,𝑙(𝑡)
provides two phases 𝜑𝑋(𝑡) and 𝜑𝑌(𝑡) from which we can
calculate the Hilbert phase difference hpd (𝑡):
hpd (𝑡) fl 𝜑𝑋 (𝑡) − 𝜑𝑌 (𝑡)
= arctan(𝑋𝑠,𝑘 (𝑡) 𝑌𝑠,𝑙 (𝑡) − 𝑋𝑠,𝑘 (𝑡) ?̃?𝑠,𝑙 (𝑡)𝑋𝑠,𝑘 (𝑡) 𝑌𝑠,𝑙 (𝑡) − 𝑋𝑠,𝑘 (𝑡) ?̃?𝑠,𝑙 (𝑡)) .
(10)
As we are thinking in windows here, the mean value mhpd
of hpd(𝑡) will serve as a measure for the phasing of two data
windows:
mhpd𝑠 (𝑘, 𝑙) fl (1𝑠 ) ⋅ ∑𝑡 hpd (𝑡) . (11)
Now the selectivity of the mhpd value can easily be deter-
mined by adapting the above described error rate calculations
for the sc value to mhpd by substituting the lsc criterion with
appropriate criteria called lmhpdpos and lmhpdneg. If sc > lsc
and mhpd < lmhpdpos the correlation between the data will
be called positive (scp). If sc > lsc and mhpd > lmhpdneg
the correlation between the data will be called negative (scn).
Conversely, if sc ≤ lsc and lmhpdpos ≤mhpd ≤ lmhpdneg the
segment is classified as not correlated (nsc).
2.4. Pressure Reactivity Index and Comparison to scp Results.
A total of 550 time segments with and without selected corre-
lation based prediction of failed autoregulationwere analyzed
by calculating the PRx in the identical periods. The entire
observation time of all time segments was 1294.1 hours. Time
segments including series with positive selected correlation
(scp) between ABP and ICP indicative for perturbed autoreg-
ulation (𝑛 = 280) and no selected correlation (nsc; 𝑛 = 270)
were imported into ICM+ software (Cambridge Enterprise,
Cambridge, UK, http://www.neurosurg.cam.ac.uk/icmplus/)
[20]. The mean duration of scp segments was 3.2 hours
(range: 1.6–51.6 hours); the mean nsc segment duration was
3.0 hours (range: 1.6–5.6). PRx was calculated as a short-term
movingPearson correlation coefficient of 10 s averages ofABP
and ICP over 5 minutes. Utilizing a PRx value higher than
0.3 as threshold for the detection of impaired autoregula-
tion, sensitivity, specificity, and positive (PPV) and negative
predictive value (NPV) were calculated for the selected cor-
relation analysis results. For outcome prediction, the mean
PRx values of each GOS class at follow-up were compared. In
addition, the percentage of time patients showed scp within
the entire observation phase was correlated to GOS at follow-
up by computing Spearman’s rank correlation analysis.
2.5. Statistics. Raw data was tested for normal distribution
using Kolmogorov–Smirnov test and averaged per segment
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Figure 1: PRx values in time segments with selected correlation
positive (scp) indicating impaired autoregulation are significantly
higher compared to no selected correlation (nsc) (mean: 0.026
versus 0.286; 𝑝 = 0.001).
prior to statistical analysis. Two- and multiple-group com-
parison was performed by computing a Wilcoxon rank sum
test and one-way ANOVA on ranks, respectively. Association
between patient’s outcome and impaired autoregulation as
detected by scp was analyzed by Spearman’s rank correlation
analysis; for prognostic impact of PRx, the mean PRx values
of each GOS class were compared.
3. Results
PRx values were significantly higher in the time segments
with scp compared to nsc (mean: 0.286 versus 0.026; 𝑝 =0.001; Figure 1). Utilizing a PRx threshold value of 0.3,
selected correlation analysis resulting in scp (mean Hilbert
phase < 70∘) predicted impairment of autoregulation with a
sensitivity of 78.8% and a specificity of 62.6%. Correspond-
ingly, the PPV of scp was 0.49; the NPV was 0.87. Mean
ICP values of time segments with scp were significantly
higher compared to nsc segments (14.4 versus 11.6mmHG;𝑝 < 0.001). The percentage of time during the observational
period in which patients showed scp, indicating a disturbed
autoregulation, correlated highly significant with patient’s
outcome as measured by the Glasgow Outcome Scale (cor-
relation coefficient (𝜌) = −0.571; 𝑝 = 0.0013; Figure 2(a)).
The mean PRx values were significantly higher in patients
with poor outcome and profoundly lower in patients with
favorable outcome (𝑝 < 0.001; Figure 2(b)).
4. Discussion
Neuroprotection after catastrophic CNS events as a causal
treatment has been the primary goal of neuroscientific
research in the field; however so far clinical trials have
not yielded any significant success in patients with either
SAH or TBI [21, 22]. In contrast, the implementation of
neurointensive care management utilizing brain multimodal
monitoring in order to provide an optimal environment
to prevent secondary injury has significantly improved the
p = 0.0013
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Figure 2: Outcome studies. (a) The percentage of time during
the observational period in which patients showed scp, indicat-
ing a disturbed autoregulation, strongly correlates with outcome
measured by GOS at the last follow-up (𝑝 = 0.0013; Spearman’s
rank correlation analysis). (b) Correspondingly, high PRx values
implicating deteriorated cerebrovascular pressure reactivity were
associated with poor outcome (ANOVA on ranks, 𝑝 < 0.001).
prognosis of patients inflicted with critical neurological
disease [23–26]. Since focusing on one single parameter
such as ICP may not be sufficient [27], treatment guidance
requires the interpretation of high resolution data sets derived
from a multitude of different monitoring devices in order
to unmask complex pathophysiological events [3]. In order
to develop a bioinformatics tool set for the integrative real-
time analysis of brain monitoring data, we have established
a mathematical model, which allows the simulation of
pathological conditions such as impaired autoregulation or
exhausted intracranial compliance [6]. Identical changes of
monitoring data resulting from this model were detected in
patients utilizing the selected correlation analysis, allowing
conclusions regarding the intracranial compliance [9] and
function of autoregulation [19]. The comparison of our
results with the pressure reactivity index (PRx) established
by Czosnyka and coworkers [10] revealed significantly higher
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PRx values in the time segments with impaired autoreg-
ulation as detected by selected correlation analysis. Using
a PRx threshold of 0.3, our approach detected changes
in autoregulation with a sensitivity of 78.8%. In addition,
both approaches resulted in a strong correlation between
detected changes of autoregulation and patients outcome.
As a limitation of our study, the size of our cohort is
relatively small and does not allow extensive statistical anal-
ysis of additional outcome parameters. However, we could
demonstrate that both approaches, scp and PRx, are related
to outcome in a similar fashion, indicating that impaired
autoregulation over a prolonged period of time is associated
with poorer outcome. It has been demonstrated that changes
of intracranial compliance, for example, following decom-
pressive craniectomy,may have significant impact on the PRx
including the determination of CPPopt [28].While Timofeev
al. [29] found increased PRx values following craniectomy,
two other studies found significantly reduced values [30, 31].
The major reason for this effect is that, after craniectomy,
the intracranial compliance is artificially increased, which
results in a flattened cerebrospinal pressure-volume curve
which impedes the transmission of blood volume changes
into ICP.This in turnmay potentially reduce the sensitivity of
the PRx towards an impaired autoregulation. It is therefore of
paramount importance to implement the aspect of intracra-
nial compliance into the analysis of autoregulation function.
Since the sca approach allows the simultaneous detection
of both major pathological conditions, reduced intracranial
compliance [9] and autoregulation failure, it may offer an
optimized platform for a computerized bedside monitoring
of patients with critical neurological diseases.
In conclusion, selected correlation analysis of brain mon-
itoring data detects impaired autoregulation with high sen-
sitivity and sufficient specificity when using the established
index PRx as comparator.
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